AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7179201
Drug: Indobufen (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indobufen (200 mg b.i.d.)
Trial: 22695241
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (TPN) for 5 postoperative days with additional oral intake ad libitum
Trial: 22695241
Drug: Oral nutrition
RxNorm normalized name: BAGS/TUBES/SUPPLIES FOR ORAL NUTRITION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nutrition alone
Trial: 12469362
Drug: nateglinide 120
RxNorm normalized name: nateglinide 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nateglinide 120 mg three times daily
Trial: 12469362
Drug: glibenclamide 5
RxNorm normalized name: glibenclamide 5 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: glibenclamide 5 mg once or twice daily
Trial: 11774671
Drug: 60 mmol/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mmol/L nitrous oxide
Trial: 11774671
Drug: 60 mmol/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mmol/L nitrous oxide with estazolam
Trial: 11774671
Drug: 40 mmol/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mmol/L nitrous oxide
Trial: 11774671
Drug: 40 mmol/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mmol/L nitrous oxide with estazolam
Trial: 2643282
Drug: Slow-release nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release nicardipine (40 mg twice a day)
Trial: 18271889
Drug: Placebo (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (twice a day)
Trial: 12579420
Drug: Tidal volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal volume of 5 ml/kg
Trial: 27988142
Drug: Filgotinib 200
RxNorm normalized name: nilotinib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filgotinib 200 mg once daily for 10 weeks
Trial: 27988142
Drug: Filgotinib (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filgotinib (all doses)
Trial: 24165696
Drug: 0.5-mg etanercept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5-mg etanercept
Trial: 24165696
Drug: 2.5-mg etanercept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5-mg etanercept
Trial: 24165696
Drug: 12.5-mg etanercept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5-mg etanercept
Trial: 22204799
Drug: Melatonin (MT)
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Melatonin (MT) 5 mg twice daily
Trial: 22204799
Drug: Tryptophan (TRP)
RxNorm normalized name: Tryptophan
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tryptophan (TRP) 250 mg twice daily
Trial: 22204799
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg twice daily + placebo
Trial: 11533324
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy plus acetazolamide (100 mg/kg/d) and furosemide (1 mg/kg/d)
Trial: 9604144
Drug: Tramadol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (100 mg/2 ml ampul)
Trial: 9604144
Drug: Morphine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (10 mg/1 ml ampul)
Trial: 9604144
Drug: Tramadol and
RxNorm normalized name: tramadol and celecoxib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol and Morphine
Trial: 8064075
Drug: Cetirizine 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 15 mg twice daily for 3 weeks
Trial: 31828287
Drug: 4gOBG (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4gOBG (10 g oat-bran)
Trial: 31828287
Drug: 2gOBG (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2gOBG (3 g oat-bran)
Trial: 31828287
Drug: 4gloMW (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4gloMW (10 g oat-bran plus β-glucanase)
Trial: 31828287
Drug: CR (Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CR (Cream of Rice)
Trial: 30317337
Drug: Intravenous tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous tranexamic acid (1.5 gm)
Trial: 21549568
Drug: Control for
RxNorm normalized name: Anti Acne Control Formula Top
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control for glucose and triglyceride levels, anticholinergic side effects, medication serum levels, cholesterol lowering medications, and pre‐study antipsychotic medications
Trial: 10334433
Drug: Omacor (n-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omacor (n-3 fatty acids) 5.1 g/day
Trial: 8921101
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg dexamethasone (group B; n = 27)
Trial: 8921101
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg dexamethasone (group C; n = 27)
Trial: 759126
Drug: Betamethasone dipropionate
RxNorm normalized name: Betamethasone Dipropionate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone dipropionate ointment
Trial: 776090
Drug: Betamethasone dipropionate
RxNorm normalized name: Betamethasone Dipropionate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone dipropionate cream
Trial: 26013241
Drug: Chloramine gel
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloramine gel (Perisolv™) applied locally followed by mechanical instrumentation
Trial: 25227897
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with fluorouracil and levamisole (5‐FU/Lev)
Trial: 24402038
Drug: Cranberry extract
RxNorm normalized name: CRANBERRY EXTRACT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry extract (36 mg proanthocyanidins per day) taken twice daily for 1 year
Trial: 24402038
Drug: Placebo taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo taken twice daily for 1 year
Trial: 18688212
Drug: Active cannabis
RxNorm normalized name: Medical Cannabis
DrugBank: Medical Cannabis (DB14009)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active cannabis (1-8% Delta-9-tetrahydrocannabinol), four times daily for 5 consecutive days
Trial: 15837996
Drug: Aprepitant regimen
RxNorm normalized name: Aprepitant
DrugBank: Aprepitant (DB00673)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprepitant regimen (day 1: APR 125 mg, OND 8 mg, dexamethasone 12 mg; days 2-3: APR 80 mg qd)
Trial: 15837996
Drug: Control regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control regimen (day 1: OND 8 mg, dexamethasone 20 mg; days 2-3: OND 8 mg bid)
Trial: 12623503
Drug: High-dose polyestradiol
RxNorm normalized name: POLYESTRADIOL
DrugBank: Polyestradiol phosphate (DB09369)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose polyestradiol phosphate (PEP) 240 mg i.m. twice a month for 2 months and thereafter once a month
Trial: 12623503
Drug: Combined androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined androgen deprivation (CAD) with flutamide (Eulexin) 250 mg t.i.d. and triptorelin (Decapeptyl) 3.75 mg per month i.m. or bilateral orchidectomy
Trial: 7696066
Drug: Temazepam 20
RxNorm normalized name: temazepam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam 20 mg orally as premedication
Trial: 2966613
Drug: Maprotiline 75
RxNorm normalized name: maprotiline 75 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maprotiline 75 mg with alcohol (1 g/kg)
Trial: 2966613
Drug: Doxepin 25
RxNorm normalized name: doxepin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxepin 25 mg with alcohol (1 g/kg)
Trial: 2966613
Drug: Zimeldine 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zimeldine 200 mg with alcohol (1 g/kg)
Trial: 2966613
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with alcohol (1 g/kg)
Trial: 28969615
Drug: Transdiagnostic internet-delivered
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdiagnostic internet-delivered cognitive behaviour therapy (iCBT)
Trial: 26289076
Drug: Dose reduction
RxNorm normalized name: Rebetron Combination Package for Rebetol Dose Reduction, Intron A 6,000,000 UNT/ML Multi-Dose Vial / 42 Rebetol Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose reduction arm
Trial: 26289076
Drug: Standard dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dosing regimen
Trial: 23013236
Drug: Odanacatib (ODN)
RxNorm normalized name: Odanacatib
DrugBank: Odanacatib (DB06670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Odanacatib (ODN) 50 mg
Trial: 23013236
Drug: Odanacatib (ODN)
RxNorm normalized name: Odanacatib
DrugBank: Odanacatib (DB06670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Odanacatib (ODN) 2-600 mg
Trial: 20653672
Drug: Oxycodone (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (15 mg orally)
Trial: 20653672
Drug: Morphine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (30 mg orally)
Trial: 20353023
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine syndrome-differentiation therapy
Trial: 16270722
Drug: Pranlukast, 450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pranlukast, 450 mg/day (n = 33)
Trial: 16270722
Drug: Sustained released
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained released Theo, 200 mg/day (n = 34)
Trial: 3285833
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg torasemide
Trial: 30762487
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection of 100 × 10^6 ADMSCs
Trial: 30762487
Drug: Two injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two injections of 100 × 10^6 ADMSCs at baseline and 6 months
Trial: 29855373
Drug: 20 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/kg praziquantel (SAC)
Trial: 29855373
Drug: 40 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/kg praziquantel (SAC)
Trial: 29855373
Drug: 60 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg/kg praziquantel (SAC)
Trial: 29855373
Drug: 20 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/kg praziquantel (PSAC)
Trial: 29855373
Drug: 60 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg/kg praziquantel (PSAC)
Trial: 26889911
Drug: Dapagliflozin 10
RxNorm normalized name: dapagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin 10 mg daily (n=58)
Trial: 23756717
Drug: Multimodal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal treatment (pharmacological and cognitive behavioral therapy)
Trial: 22437554
Drug: α-tocopherol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α-tocopherol (50 mg/d) supplementation
Trial: 18818960
Drug: Aspirin therapy
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin therapy (best medical management)
Trial: 15090799
Drug: Metformin and
RxNorm normalized name: metformin and acarbose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin and exercise training (1 hour of aerobic and resistance training three times a week)
Trial: 9743817
Drug: Chondroitin sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulfate (CS, Condrosulf, IBSA, Lugano, CH) 2 x 400 mg/day
Trial: 8092558
Drug: Loratadine, 10
RxNorm normalized name: Loratadine, 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine, 10 mg once daily for 6 weeks
Trial: 10328395
Drug: Propamidine isethionate
RxNorm normalized name: propamidine isethionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propamidine isethionate 0.1% ophthalmic solution (Brolene) and neomycin-polymyxin B-gramicidin ophthalmic solution (Neotricin)
Trial: 8125424
Drug: Captopril (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50 mg/day)
Trial: 2022303
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (30 ml containing 3.8 g EPA and 2.5 g DHA)
Trial: 28408010
Drug: Avoidance of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avoidance of treatment-related heart attack risk
Trial: 28408010
Drug: Control for
RxNorm normalized name: Anti Acne Control Formula Top
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control for treatment-related heart attack risk
Trial: 25995282
Drug: High-Protein (HP)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Protein (HP) snack (26 g of protein/6 g of fat per 27 g of carbohydrates)
Trial: 25995282
Drug: High-Fat (HF)
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Fat (HF) snack (4 g of protein/12 g of fat per 32 g of carbohydrates)
Trial: 24722445
Drug: 0.75 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 mg/d atrasentan
Trial: 24722445
Drug: 1.25 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg/d atrasentan
Trial: 24722445
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses of atrasentan
Trial: 24722445
Drug: Atrasentan (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrasentan (both doses)
Trial: 22831874
Drug: Single, oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single, oral supplementation of 100,000 IU vitamin D3
Trial: 17524997
Drug: Transdermal 17beta-estradiol
RxNorm normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal 17beta-estradiol gel at 1.25 g/day (0.75 mg/day)
Trial: 17524997
Drug: Transdermal 17beta-estradiol
RxNorm normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal 17beta-estradiol gel at 2.5 g/day (1.5 mg/day)
Trial: 17524997
Drug: Transdermal 17beta-estradiol
RxNorm normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal 17beta-estradiol gel at 5.0 g/day (3 mg/day)
Trial: 17524997
Drug: Estriol 2
RxNorm normalized name: estriol 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estriol 2 mg/day p.o. (control)
Trial: 15545824
Drug: Methylprednisolone (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (15 mg/kg) added to the CPB priming solution (Group MP, n = 37)
Trial: 11350567
Drug: Lisinopril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (20 mg o.d.)
Trial: 10204735
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg pethidine (P50)
Trial: 10204735
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg pethidine (P100)
Trial: 10204735
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg pethidine (P200)
Trial: 28983938
Drug: Moisturizing skincare
RxNorm normalized name: MOISTURIZER
DrugBank: Homosalate (DB11064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moisturizing skincare (bathing every 2 days and using lotion daily)
Trial: 28983938
Drug: Daily bathing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily bathing without lotion (control)
Trial: 27657522
Drug: ICS/LABA combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICS/LABA combination
Trial: 27657522
Drug: ICS monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICS monotherapy
Trial: 15758763
Drug: Pentosan polysulfate
RxNorm normalized name: Pentosan polysulfate
DrugBank: Pentosan polysulfate (DB00686)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentosan polysulfate sodium (PPS) 300 mg, 3 times daily
Trial: 8864316
Drug: Pravastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (40 mg orally)
Trial: 6594157
Drug: Extra-amniotic infusion
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra-amniotic infusion of prostaglandin E2 (PGE2)
Trial: 3514164
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of prednisone daily for 2 weeks
Trial: 3514164
Drug: Baseline spirometric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline spirometric data and beta‐agonist responsiveness
Trial: 27874299
Drug: TACO (immersion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TACO (immersion in 151 L of 2.1°C ± 0.8°C water)
Trial: 24780728
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g dried plum/d
Trial: 24780728
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g dried apple/d (comparative control)
Trial: 23248893
Drug: Multi-directional power
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-directional power toothbrush (Oral-B Vitality TriZone)
Trial: 20447049
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin type A (BTA) injection combined with 10 sessions of physical and occupational therapy followed by 10 sessions of neuromuscular electrical stimulation on the wrist extensors
Trial: 15733028
Drug: Combined sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined sequential HRT
Trial: 6363155
Drug: Arginine thiazolidinecarboxylate
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine thiazolidinecarboxylate (800 mg/day for 40 days)
Trial: 31489424
Drug: Continuous oral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous oral health education
Trial: 31489424
Drug: Routine oral
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine oral hygiene education (Control)
Trial: 20519079
Drug: Yitongshu injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yitongshu injection (4 ml) into the Zusanli point on both sides 11 hours or 23 hours after administration of the drugs.
Trial: 17425758
Drug: Amlodipine-enalapril combination
RxNorm normalized name: enalapril / felodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine-enalapril combination
Trial: 15781019
Drug: Docosahexaenoic acid
RxNorm normalized name: docosahexaenoic acid
DrugBank: Doconexent (DB03756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docosahexaenoic acid (1.2 g/day for 6 weeks)
Trial: 10809859
Drug: Hypericum ointment
RxNorm normalized name: Hypericum oil
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypericum ointment
Trial: 6433319
Drug: Heparin (1
RxNorm normalized name: 2,3-o-Desulfated heparin (12000 da)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (1 U/mL) added to intravenous alimentation solutions
Trial: 782146
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no heparin)
Trial: 31053295
Drug: Serum antibodies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum antibodies to neuronal proteins
Trial: 28685542
Drug: Continuous blood
RxNorm normalized name: Dexcom G6 Receiver Continuous Blood-Glucose M
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous blood purification (CBP) in addition to conventional therapy
Trial: 26158927
Drug: HSM‐IOL (heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HSM‐IOL (heparin surface modified intraocular lens)
Trial: 23384411
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of human umbilical tissue-derived cells (hUTC) into the nucleus pulposus (NP)
Trial: 23384411
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of hydrogel carrier alone
Trial: 23384411
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of human umbilical tissue-derived cells (hUTC) with hydrogel carrier
Trial: 23384411
Drug: Punctured group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Punctured group (no treatment)
Trial: 21740403
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy as an adjunct to pharmacological therapy
Trial: 21740403
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard pharmacological therapy only)
Trial: 18505387
Drug: AmB, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AmB, 1 mg/kg per day, plus flucytosine, 25 mg/kg 4 times per day (group 2)
Trial: 18505387
Drug: AmB, 0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AmB, 0.7 mg/kg per day, plus flucytosine, 25 mg/kg 4 times per day (group 1)
Trial: 17063641
Drug: Thyme-ivy combination
RxNorm normalized name: THYME
DrugBank: Thyme (DB10983)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyme-ivy combination syrup (5.4 ml three times daily for 11 days)
Trial: 17063641
Drug: Thyme-ivy combination
RxNorm normalized name: THYME
DrugBank: Thyme (DB10983)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyme-ivy combination syrup